• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

TCT 2020

Boston Scientific shares slide on TAVR study results

October 15, 2020 By Nancy Crotti

Shares in Boston Scientific (NYSE:BSX) slid nearly 4% on news that the rates of cardiac death in patients implanted with its Acurate Neo heart valve were significantly higher than those in patients who received Medtronic’s (NYSE:MDT) CoreValve Evolut. The head-to-head SCOPE II study, presented today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation, […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, Medtronic, TCT 2020

Abbott touts Xience DES study results

October 15, 2020 By Nancy Crotti

A pair of studies of Abbott’s Xience drug-eluting stent showed no difference between shorter courses of treatment with dual antiplatelet therapy (DAPT) compared with 12 months of DAPT following implantation of the XIENCE drug-eluting stent (DES) in patients who are at a high risk of bleeding. Abbott presented the late-breaking data today at TCT Connect, […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Eluting Stents, Featured, Stents Tagged With: Abbott, TCT 2020

Abiomed touts latest Impella trial results

October 15, 2020 By Nancy Crotti

Abiomed (NSDQ:ABMD) today announced interim results of a study that found high-risk patients had better outcomes after implantation with its Impella CP heart pump. Data from the PROTECT III FDA post-approval study of Impella 2.5 and Impella CP in high-risk percutaneous coronary intervention (PCI) patients showed reduced rates of MACCE — a composite of death, stroke, […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Implants Tagged With: Abiomed, FDA, TCT 2020

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS